Drug Development. Are trade secrets delaying biosimilars?
Publication
, Journal Article
Price, WN; Rai, AK
Published in: Science (New York, N.Y.)
April 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Science (New York, N.Y.)
DOI
EISSN
1095-9203
ISSN
0036-8075
Publication Date
April 2015
Volume
348
Issue
6231
Start / End Page
188 / 189
Related Subject Headings
- United States Food and Drug Administration
- United States
- General Science & Technology
- Drug Industry
- Drug Discovery
- Drug Costs
- Drug Approval
- Confidentiality
- Biosimilar Pharmaceuticals
Citation
APA
Chicago
ICMJE
MLA
NLM
Price, W. N., & Rai, A. K. (2015). Drug Development. Are trade secrets delaying biosimilars? Science (New York, N.Y.), 348(6231), 188–189. https://doi.org/10.1126/science.aab1684
Price, W Nicholson, and Arti K. Rai. “Drug Development. Are trade secrets delaying biosimilars?” Science (New York, N.Y.) 348, no. 6231 (April 2015): 188–89. https://doi.org/10.1126/science.aab1684.
Price WN, Rai AK. Drug Development. Are trade secrets delaying biosimilars? Science (New York, NY). 2015 Apr;348(6231):188–9.
Price, W. Nicholson, and Arti K. Rai. “Drug Development. Are trade secrets delaying biosimilars?” Science (New York, N.Y.), vol. 348, no. 6231, Apr. 2015, pp. 188–89. Epmc, doi:10.1126/science.aab1684.
Price WN, Rai AK. Drug Development. Are trade secrets delaying biosimilars? Science (New York, NY). 2015 Apr;348(6231):188–189.
Published In
Science (New York, N.Y.)
DOI
EISSN
1095-9203
ISSN
0036-8075
Publication Date
April 2015
Volume
348
Issue
6231
Start / End Page
188 / 189
Related Subject Headings
- United States Food and Drug Administration
- United States
- General Science & Technology
- Drug Industry
- Drug Discovery
- Drug Costs
- Drug Approval
- Confidentiality
- Biosimilar Pharmaceuticals